ReviewRSC advances2025
Role of noble and rare earth metals in bioactive materials for medical applications in tissue engineering.
Review in RSC advances, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Tissue engineering (TE) is an interdisciplinary field that is developing rapidly. It combines medicine, chemistry, and biology to create functional biological materials that can restore or replace damaged tissues and organs. However, the potential of bioactive metals to improve the mechanical properties of tissue engineering scaffolds is largely unexplored. Our review of recent literature, focusing primarily on research conducted between 2020 and 2025, reveals common applications of these two metal groups, including bone and soft tissue regeneration, wound healing, and anticancer therapy. It also reveals differences in their use, highlighting the abundance of rare earth elements (REE) applications in the medical field for imaging and diagnostics, medical lasers, and radiation shielding and protection. The role of REEs in drug delivery systems distinguishes them from noble metals in medical applications. Here, we demonstrate that noble metals and REEs can significantly enhance the strength and fracture resistance of tissue engineering scaffolds. In the form of nanoparticles, these metals enhance biocompatibility, ensuring seamless integration with biological tissues and reducing the risk of adverse reactions. Key findings from the literature review highlight future directions for noble metal and REE applications in TE and medicine, including the multifunctionality of new biomaterials (particularly REE biomaterials), smart nanomaterials that respond to various changes in organisms, hydroxyapatite (HAP) doped with REEs, and surface modifications (particularly Pt-, Au- and Ag-doped materials) to create multifunctional implants that can better integrate with biological tissues and reduce infection risks.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.